Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Critical RiskFDA Drug
Medications & Supplements/Prescription Drugs

MasterPharm LLC: Minoxidil/Biotin/Spironolactone Capsules Recalled for High Potency Risk

Agency Publication Date: June 26, 2020
Share:
Sign in to monitor this recall

Summary

MasterPharm LLC is recalling approximately 300 bottles of Minoxidil/Biotin/Spironolactone compounded capsules (1.25/5/25 mg) because they contain dangerously high levels of minoxidil and biotin. This super-potent formulation can lead to serious cardiovascular issues or other health complications. These compounded drugs were distributed in 90-count bottles to patients in Florida and Maryland and were not intended for resale. If you have this medication, you should contact your doctor or pharmacist immediately for guidance and a refund.

Risk

The elevated levels of minoxidil can cause a sudden drop in blood pressure, rapid heartbeat, or fluid retention, while excessive biotin can interfere with important clinical lab tests. No specific injuries were reported at the time of the recall, but the super-potent dosage poses a critical health risk to patients.

What You Should Do

  1. Check your prescription bottle for a 90-count bottle of 'Minoxidil/Biotin/Spironolactone 1.25/5/25 mg capsule' from MasterPharm.
  2. Verify if your bottle matches Lot number 01-09-2020:13@8 (Lot: 01-09-2020) with an expiration date of 7/7/2020.
  3. Stop taking this medication immediately if it matches the affected lot information.
  4. Contact your healthcare provider or pharmacist right away to discuss your treatment and any potential side effects you may be experiencing.
  5. Return any unused capsules to MasterPharm LLC at 115-02 Liberty Ave, Richmond Hill, NY 11419 for a refund.
  6. Contact MasterPharm LLC directly for further instructions regarding this recall.
  7. For additional questions, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA).

Your Remedy Options

๐Ÿ’ฐFull Refund

Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Minoxidil/Biotin/Spironolactone 1.25/5/25 mg capsule (90 capsules)
Model:
D-1363-2020
Lot Numbers:
01-09-2020:13@8 (Exp. 7/7/2020)
01-09-2020
Date Ranges: Expiration date 7/7/2020

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 85839
Status: Resolved
Manufacturer: MasterPharm LLC
Sold By: MasterPharm LLC
Manufactured In: United States
Units Affected: 300 capsules
Distributed To: Florida, Maryland

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.